Stock BAYNd BAYER AG
Add to a list

Bayer AG Share Price CBOE EUROPE EQUITIES - EUROPEAN EQUITIES (NL)

Stocks

BAYNd

DE000BAY0017

Pharmaceuticals

OTC Markets Traded
Market Closed - CBOE EUROPE EQUITIES - EUROPEAN EQUITIES (NL)
Other stock markets
 09:00:00 17/06/2026 pm IST 		5-day change 1st Jan Change
37.89 EUR +5.37% Intraday chart for Bayer AG +2.48% -33.31%
18/06 BAYER AG : Jefferies reiterates its Neutral rating ZD
17/06 DAX Index Climbs; BMW Drops on FY26 Profit Warning MT
Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Bayer AG

Market Cap 3.71TCr 4.3TCr 3.41TCr 3.21TCr 6.03TCr 4,05600Cr 6.08TCr 40TCr 16TCr 1,99100Cr 16TCr 16TCr 6,88600Cr P/E 2026 *
16x
P/E 2027 * 12.1x
Enterprise Value 6.88TCr 7.97TCr 6.32TCr 5.95TCr 11TCr 7,52300Cr 11TCr 75TCr 29TCr 3,69200Cr 30TCr 29TCr 12,77300Cr EV / Sales 2026 *
1.51x
EV / Sales 2027 * 1.4x
Free-Float
100%
Yield 2026 *
0.59%
Yield 2027 * 1.96%
* Estimated data More valuation ratios

Chart: Bayer AG

Dynamic Chart

Latest news : Bayer AG

18/06 BAYER AG : Jefferies reiterates its Neutral rating ZD
17/06 DAX Index Climbs; BMW Drops on FY26 Profit Warning MT
17/06 Bayer's $7.25 Billion U.S. Settlement Over Roundup Sent Back to Missouri Court DJ
17/06 Federal judge sends Bayer's $7.25 billion Roundup settlement back to Missouri state court RE
17/06 Bayer Aktiengesellschaft completed the acquisition of Perfuse Therapeutics, Inc. CI
17/06 Bayer Hits Monthly High Despite Legal Ambiguity in the U.S. DP
17/06 Genetic Engineering in Supermarkets: EU Relaxes Regulations DP
17/06 Bayer Hits Monthly High Despite Legal Ambiguities in the U.S. DP
17/06 Bayer Finalizes Acquisition of California-Based Perfuse Therapeutics to Boost Ophthalmology Unit Zonebourse
17/06 UBS Projects $28 Price Target for Bayer in 'Worst-Case' Scenario DP
17/06 BAYER AG : UBS gives a Buy rating ZD
17/06 Bayer Acquires US-based Perfuse Therapeutics MT
15/06 Bayer Receives FDA Approval for Ambelvist for Contrast-Enhanced MRI to Detect and Visualize Lesions with Abnormal Vascularity CI
More news

Last Transcript: Bayer AG

Logo Bayer AG
Bayer Aktiengesellschaft, Q1 2026 Earnings Call, May 12, 2026
12/05
More transcripts

Analysts' recommendations: Bayer AG

18/06 BAYER AG : Jefferies reiterates its Neutral rating ZD
17/06 Bayer Hits Monthly High Despite Legal Ambiguity in the U.S. DP
17/06 Bayer Hits Monthly High Despite Legal Ambiguities in the U.S. DP
17/06 UBS Projects $28 Price Target for Bayer in 'Worst-Case' Scenario DP
17/06 BAYER AG : UBS gives a Buy rating ZD
More recommendations

Press Releases: Bayer AG

17/06 Bayer : Federal judge remands Monsanto class settlement case back to Missouri State Court PU
17/06 Bayer Completes Acquisition of Perfuse Therapeutics BU
16/06 Aleve® Launches its Project DIY Campaign with HGTV Stars Dave & Jenny Marrs to Highlight Hardworking Hobbyists and Long-Lasting Pain Relief BU
15/06 Bayer : Expands Open Innovation Network in China with New Hub in Shandong Province PU
15/06 Bayer : low-dose MRI contrast agent approved in U.S. PU
More press releases

News in other languages: Bayer AG

17/06 Freundlich - Autoaktien von BMW ausgebremst
17/06 Bayer erleichtert: Richter schickt US-Sammelvergleich zurück in Bundesstaat
17/06 Bayer : Bundesrichter verweist Entscheidung über den Sammelvergleich von Monsanto zurück an das Gericht im US-Bundesstaat Missouri
17/06 XETRA-SCHLUSS/DAX wenig bewegt - BMW-Aktie knickt nach Gewinnwarnung ein
17/06 Gericht verweist Bayers Roundup-Vergleich zurück nach Missouri
More news

Quotes and Performance

1 week+6.94%
Current month+4.50%
1 month+0.70%
3 months-5.89%
6 months+8.01%
Current year+2.42%

Course Extremes

1 week 35.44
Extreme 35.44
 38.58
1 month 32.9
Extreme 32.9
 39.46
3 years 18.39
Extreme 18.39
 53.79
5 years 18.39
Extreme 18.39
 67.99

Managers and Directors: Bayer AG

Manager TitleAgeSince
William Anderson CEO
 Chief Executive Officer 59 01/06/2023
Judith Hartmann DFI
 Director of Finance/CFO 57 01/06/2026
Christian Rommel CTO
 Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
André van Broich BRD
 Director/Board Member 56 01/04/2012
Heinz Georg Webers BRD
 Director/Board Member 66 01/04/2022
Heike Hausfeld BRD
 Director/Board Member 60 01/04/2017
More insiders

Other Pharmaceuticals

Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Change 5-day change 1-year change 3-year change Capi.($)
BAYER AG Stock Bayer AG
+5.37%+2.48%+40.05%-27.46% 4.11TCr
ELI LILLY AND COMPANY Stock Eli Lilly and Company
-0.94%-2.14%+40.54%+148.38% 1,00100Cr
JOHNSON & JOHNSON Stock Johnson & Johnson
-0.42%-1.80%+53.69%+42.60% 57TCr
ABBVIE INC. Stock AbbVie Inc.
-0.56%-1.65%+19.27%+59.57% 39TCr
ROCHE HOLDING AG Stock Roche Holding AG
-1.18%+0.68%+24.66%+16.53% 33TCr
NOVARTIS AG Stock Novartis AG
+1.09%+1.65%+26.61%+33.32% 28TCr
ASTRAZENECA PLC Stock AstraZeneca PLC
+1.42%+0.06%+26.36%+14.29% 28TCr
NOVO NORDISK A/S Stock Novo Nordisk A/S
+1.87%+0.87%-41.49%-48.26% 19TCr
AMGEN INC. Stock Amgen Inc.
-1.78%+1.16%+17.79%+48.77% 19TCr
GILEAD SCIENCES, INC. Stock Gilead Sciences, Inc.
-1.40%+3.27%+16.16%+59.08% 16TCr
Average -0.21%+0.70%+22.36%+34.68% 37.52TCr
Weighted average by Cap. -0.38%-0.36%+29.48%+65.14%
See all sector performances

Financials

2026 *2027 *
Net sales 4.55TCr 5.28TCr 4.19TCr 3.94TCr 7.41TCr 4,98200Cr 7.47TCr 50TCr 19TCr 2,44500Cr 20TCr 19TCr 8,45800Cr 4.68TCr 5.43TCr 4.3TCr 4.05TCr 7.61TCr 5,12100Cr 7.68TCr 51TCr 20TCr 2,51300Cr 20TCr 20TCr 8,69400Cr
Net income 217.15Cr 251.71Cr 199.65Cr 187.91Cr 353.11Cr 24TCr 356.07Cr 2.37TCr 921.12Cr 12TCr 944.73Cr 924.55Cr 40TCr 299.62Cr 347.3Cr 275.46Cr 259.27Cr 487.2Cr 33TCr 491.29Cr 3.26TCr 1.27TCr 16TCr 1.3TCr 1.28TCr 56TCr
Net Debt 3.17TCr 3.67TCr 2.91TCr 2.74TCr 5.15TCr 3,46700Cr 5.2TCr 35TCr 13TCr 1,70200Cr 14TCr 13TCr 5,88700Cr 2.86TCr 3.32TCr 2.63TCr 2.48TCr 4.65TCr 3,13100Cr 4.69TCr 31TCr 12TCr 1,53700Cr 12TCr 12TCr 5,31700Cr
* Estimated data More financial data

Company Profile

Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
-
Sector
Pharmaceuticals
Calendar
Earnings release - Q2 2026
More about the company

Quotes

Date Price Change
17/26/17 37.89 € +5.37%
16/26/16 35.96 € -0.50%
15/26/15 36.14 € -0.14%
12/26/12 36.19 € +0.72%
11/26/11 35.93 € +1.41%

Real-time CBOE EUROPE EQUITIES - EUROPEAN EQUITIES (NL)

More quotes
  1. Stock Market
  2. Stocks
  3. BAYN Stock
  4. BAYNd Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

MarketScreener
United-States
MarketScreener Canada
Canada

MIDDLE EAST

MarketScreener Saudi Arabia
Saudi Arabia
MarketScreener UAE Emirates
United Arab Emirates

EUROPE

Zonebourse
France
MarketScreener Deutschland
Deutschland
Zonebourse Suisse
Suisse
MarketScreener Schweiz
Schweiz
MarketScreener Italia
Italia
MarketScreener Österreich
Österreich
MarketScreener België
België
MarketScreener Nederland
Nederland
MarketScreener España
España
MarketScreener Sverige
Sverige
MarketScreener UK
United Kingdom

APAC

MarketScreener Australia
Australia
MarketScreener India
India
MarketScreener Hong Kong
Hong Kong